EAGLE ASSET MANAGEMENT INC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$104,981,000
+15.7%
549,755
-0.4%
0.54%
+4.8%
Q2 2020$90,711,000
+43.0%
551,875
+0.4%
0.52%
+30.6%
Q1 2020$63,445,000
+0.1%
549,881
-0.9%
0.40%
+29.5%
Q4 2019$63,384,000
+32.9%
554,739
-14.8%
0.30%
+20.1%
Q1 2019$47,682,000
+37.5%
651,039
+6.3%
0.25%
+16.5%
Q4 2018$34,687,000
-20.9%
612,213
+7.6%
0.22%
+2.8%
Q3 2018$43,873,000
+16.2%
568,902
+0.1%
0.21%
+4.4%
Q2 2018$37,747,000
+143.4%
568,567
+89.6%
0.20%
+116.0%
Q2 2017$15,511,000
+28.5%
299,804
+56.1%
0.09%
+23.7%
Q1 2017$12,069,000
+31.8%
192,011
+10.6%
0.08%
+26.7%
Q4 2016$9,160,000
-60.0%
173,589
-70.8%
0.06%
-23.1%
Q3 2015$22,922,000
+22.0%
594,490
+53.2%
0.08%
-25.7%
Q2 2015$18,787,000
-36.5%
388,173
-53.6%
0.10%
-37.9%
Q1 2015$29,578,000
-31.5%
836,723
-37.8%
0.17%
-32.1%
Q4 2014$43,192,000
-56.3%
1,344,297
-49.4%
0.25%
-12.0%
Q3 2014$98,772,000
+107.1%
2,656,600
+113.1%
0.28%
+9.3%
Q2 2014$47,685,000
-39.9%
1,246,667
-28.4%
0.26%
-40.7%
Q1 2014$79,372,000
-53.1%
1,742,147
-58.9%
0.44%
-8.2%
Q4 2013$169,150,000
+88.9%
4,240,430
+108.1%
0.48%
+7.2%
Q3 2013$89,556,000
+47.8%
2,038,156
+5.8%
0.44%
+10.7%
Q2 2013$60,612,0001,926,6610.40%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders